These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27746365)

  • 1. The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.
    Chen X; Lu P; Wang DD; Yang SJ; Wu Y; Shen HY; Zhong SL; Zhao JH; Tang JH
    Gene; 2016 Dec; 595(2):221-226. PubMed ID: 27746365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-4443 Participates in the Malignancy of Breast Cancer.
    Chen X; Zhong SL; Lu P; Wang DD; Zhou SY; Yang SJ; Shen HY; Zhang L; Zhang XH; Zhao JH; Tang JH
    PLoS One; 2016; 11(8):e0160780. PubMed ID: 27504971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens.
    Peskoe SB; Barber JR; Zheng Q; Meeker AK; De Marzo AM; Platz EA; Lupold SE
    BMC Cancer; 2017 Jan; 17(1):32. PubMed ID: 28061773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.
    Yin JY; Deng ZQ; Liu FQ; Qian J; Lin J; Tang Q; Wen XM; Zhou JD; Zhang YY; Zhu XW
    Int J Clin Exp Pathol; 2014; 7(7):4261-7. PubMed ID: 25120807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.
    Boisen MK; Dehlendorff C; Linnemann D; Schultz NA; Jensen BV; Høgdall EV; Johansen JS
    BMC Cancer; 2015 Dec; 15():1024. PubMed ID: 26714641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
    Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
    Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues.
    Gomes BC; Santos B; Rueff J; Rodrigues AS
    Methods Mol Biol; 2016; 1395():189-205. PubMed ID: 26910075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression level of miR-93 in formalin-fixed paraffin-embedded tissues of breast cancer patients.
    Deng ZQ; Qian J; Liu FQ; Lin J; Shao R; Yin JY; Tang Q; Zhang M; He L
    Genet Test Mol Biomarkers; 2014 May; 18(5):366-70. PubMed ID: 24606013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.
    Strauss P; Marti HP; Beisland C; Scherer A; Lysne V; Leh S; Flatberg A; Koch E; Beisvag V; Landolt L; Skogstrand T; Eikrem Ø
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
    Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
    J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors.
    Tanic M; Yanowski K; Gómez-López G; Rodriguez-Pinilla MS; Marquez-Rodas I; Osorio A; Pisano DG; Martinez-Delgado B; Benítez J
    Int J Cancer; 2015 Feb; 136(3):593-602. PubMed ID: 24917463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.
    Loudig O; Wang T; Ye K; Lin J; Wang Y; Ramnauth A; Liu C; Stark A; Chitale D; Greenlee R; Multerer D; Honda S; Daida Y; Spencer Feigelson H; Glass A; Couch FJ; Rohan T; Ben-Dov IZ
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
    Teoh SL; Das S
    Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
    Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.